Recommendations updated for HIV treatment, prevention

Recommendations updated for HIV treatment, prevention

(HealthDay)—In a 2020 guideline from the International Antiviral Society-U.S., published online Oct. 14 in the Journal of the American Medical Association, updated recommendations are presented for the treatment and prevention of HIV.

Michael S. Saag, M.D., from the University of Alabama at Birmingham, and colleagues collected new evidence since the previous International Antiviral Society-U.S. recommendations, issued in 2018, examined new data, and incorporated them into current recommendations.

The authors included 549 citations to form the evidence basis for the recommendations. For all individuals with HIV who have detectable viremia, is recommended as soon as possible. Most can start with a three- or two-drug regimen, incorporating an integrase strand transfer inhibitor. For patients who may be pregnant, those with specific clinical conditions, those with opportunistic diseases, or those with health care access issues, effective options are available. A long-acting antiretroviral regimen injected once every four weeks for treatment or every eight weeks, pending approval by and availability, is recommended for the first time. Preexposure prophylaxis with an oral regimen is recommended for individuals at risk for HIV. Monitoring for effectiveness and safety is recommended before and during therapy. At this time, switching therapy for virological failure is relatively rare.

"Whether HIV is an for worse COVID-19 outcomes is still under evaluation," the authors write. "Persons with HIV should be prioritized for SARS-CoV-2 testing and closely monitored for complications."

Several authors disclosed financial ties to the biopharmaceutical industry.

Explore further

2016 recommendations for antiretroviral drugs for the treatment and prevention of HIV infection

More information: Abstract/Full Text

Copyright © 2020 HealthDay. All rights reserved.

Citation: Recommendations updated for HIV treatment, prevention (2020, October 26) retrieved 19 August 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors